Gufic Biosciences Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join now and be among the first to discover Stock Ideas

Get the Stocks!

Please wait...

Annual
Quarterly

Please wait...

Please wait...

Please wait...

Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 686.46 Cr

Revenue (TTM): R 367.71 Cr

Earnings (TTM): R 24.15 Cr

Cash: R 7.59 Cr

Total Debt: R 97.79 Cr

Promoters' ownership: 65.75%

Liquidity: Moderate

52 Week range: R 37.00 - 101.00

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

CFO: 29.26 Cr
EBITDA: 183.11 Cr
Net Profit: 70.73 Cr

Stock Performance

Trailing
Annual

Time Period	Gufic Biosciences	S&P BSE Healthcare*	S&P BSE Small Cap*
YTD	44.12	23.40	-6.54
1 month	36.74	1.46	7.10
3 months	40.78	13.86	24.38
1 Year	22.87	29.91	-6.53
3 Years	6.99	4.43	-6.96
5 Years	41.81	-0.57	2.46
10 Years	29.01	11.15	3.28

As on 13-Jul-2020 *As on 10-Jul-2020

Year	Gufic Biosciences	S&P BSE Small Cap	S&P BSE Healthcare
2019	-35.40	-6.85	-3.55
2018	-26.15	-23.41	-5.89
2017	138.25	59.64	0.49
2016	-4.49	1.77	-12.88
2015	225.15	6.76	15.06

Annual Report (FY19)

News & Announcements